Influence of coronary collateral vessels on myocardial infarct size in humans: results of phase I Thrombolysis in Myocardial Infarction (TIMI) trial: the TIMI Investigators, Circulation, vol.83, pp.739-746, 1991. ,
The human coronary collateral circulation, Eur J Clin Invest, vol.40, pp.465-476, 2010. ,
Clinical implications of the "no reflow" phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction, Circulation, vol.93, pp.223-228, 1996. ,
Targeting angiogenesis to restore the microcirculation after reperfused MI, Nat Rev Cardiol, vol.6, pp.515-523, 2009. ,
Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure, J Clin Invest, vol.115, pp.2108-2118, 2005. ,
The VIVA trial: Vascular Endothelial Growth Factor in Ischemia for Vascular Angiogenesis, Circulation, vol.107, pp.1359-1365, 2003. ,
Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial, Circulation, vol.105, pp.788-793, 2002. ,
Arteriogenesis: lessons learned from clinical trials, Endothelium, vol.10, pp.217-223, 2003. ,
Angiogenesis therapy: amidst the hype, the neglected potential for serious side effects, Circulation, vol.104, pp.115-119, 2001. ,
Growing better blood vessels, Nat Biotechnol, vol.19, pp.1019-1020, 2001. ,
Polymeric system for dual growth factor delivery, Nat Biotechnol, vol.19, pp.1029-1034, 2001. ,
Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2, Nat Med, vol.9, pp.604-613, 2003. ,
Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial, Circulation, vol.100, pp.1865-1871, 1999. ,
Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis, J Clin Invest, vol.113, pp.516-527, 2004. ,
Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action, Blood, vol.107, pp.3531-3536, 2006. ,
Mixed-wall microcapsules made of cross-linked proteins and polysaccharides: preparation and properties, J Microencapsul, vol.8, pp.335-347, 1991. ,
Coating alginate microspheres with a serum albumin-alginate membrane: application to the encapsulation of a peptide, Eur J Pharm Sci, vol.24, pp.187-197, 2005. ,
URL : https://hal.archives-ouvertes.fr/inserm-00069190
Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure, Circulation, vol.109, pp.1674-1679, 2004. ,
Early versus delayed angiotensin-converting enzyme inhibition in experimental chronic heart failure: effects on survival, hemodynamics, and cardiovascular remodeling, Circulation, vol.95, pp.1314-1319, 1997. ,
High-resolution myocardial perfusion mapping in small animals in vivo by spin-labeling gradient-echo imaging, Magn Reson Med, vol.51, pp.62-67, 2004. ,
URL : https://hal.archives-ouvertes.fr/hal-02119122
Magnetization exchange in capillaries by microcirculation affects diffusioncontrolled spin-relaxation: a model which describes the effect of perfusion on relaxation enhancement by intravascular contrast agents, Magn Reson Med, vol.35, pp.43-55, 1996. ,
Protein release from alginate matrices, Adv Drug Deliv Rev, vol.31, issue.3, pp.267-285, 1998. ,
Controlled growth factor release from synthetic extracellular matrices, Nature, vol.408, pp.998-1000, 2000. ,
Hydrogels for tissue engineering: scaffold design variables and applications, Biomaterials, vol.24, pp.4337-4351, 2003. ,
Myocardial hypertrophy in the absence of external stimuli is induced by angiogenesis in mice, J Clin Invest, vol.117, pp.3188-3197, 2007. ,
Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells, Hypertension, vol.37, pp.581-586, 2001. ,
Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis, J Clin Invest, vol.117, pp.2766-2777, 2007. ,
Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets, Gene Ther, vol.7, pp.417-427, 2000. ,
Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model, Circulation, vol.95, pp.2552-2558, 1997. ,
Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia, Gene Ther, vol.17, pp.1152-1161, 2010. ,
Fibroblast growth factor-2 decreases metabolic coupling and stimulates phosphorylation as well as masking of connexin43 epitopes in cardiac myocytes, Circ Res, vol.79, pp.647-658, 1996. ,
Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction in cardiomyopathic hamster hearts, Am J Physiol Heart Circ Physiol, vol.288, pp.2131-2139, 2005. ,
Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis, Circulation, vol.97, pp.381-390, 1998. ,
Hepatocyte growth factor/scatter factor can induce angiogenesis independently of vascular endothelial growth factor, Arterioscler Thromb Vasc Biol, vol.23, pp.69-75, 2003. ,
Hepatocyte growth factor mediates angiopoietin-induced smooth muscle cell recruitment, Blood, vol.108, pp.1260-1266, 2006. ,
Toward delivery of multiple growth factors in tissue engineering, Biomaterials, vol.31, pp.6279-6308, 2010. ,
Differences in relative expression levels were calculated according to the ??Ct (cycle threshold) method by Pfaffer et al. Statistics Data are presented as mean ± SEM. Student's t-test (two-tailed) was used to compare two groups of independent samples. For multiple comparisons, data distribution was analyzed by D'Agoustino and Pearson's omnibus normality test using GraphPad Prism software (version 5.0). For data sets with normal distribution, one-way analysis of variance (ANOVA) was employed, followed by Tukey's post-hoc test, except for echocardiographic data where repeated measurements two-way ANOVA was used followed by Bonferroni post-hoc test. For data sets with non Gaussian distribution, 12-24 RT-PCRs being carried out per gene for each condition. Data were analyzed using the Light Cycler software, vol.10, 2011. ,
Mixed-wall microcapsules made of cross-linked proteins and polysaccharides: preparation and properties, J Microencapsul, vol.8, pp.335-347, 1991. ,
Free amino group content of serum albumin microcapsules III: a study at low pH values, Int J Pharm, vol.128, pp.197-202, 1996. ,
Serum albumin-alginate coated microspheres: role of the inner gel in binding and release of the KRFK peptide, Int J Pharm, vol.366, pp.103-110, 2009. ,
Coating alginate microspheres with a serum albumin-alginate membrane: application to the encapsulation of a peptide, Eur J Pharm Sci, vol.24, pp.187-197, 2005. ,
URL : https://hal.archives-ouvertes.fr/inserm-00069190
Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action, Blood, vol.107, pp.3531-3536, 2006. ,
Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure, Circulation, vol.109, pp.1674-1679, 2004. ,
Early versus delayed angiotensin-converting enzyme inhibition in experimental chronic heart failure. Effects on survival, hemodynamics, and cardiovascular remodeling, Circulation, vol.95, pp.1314-1319, 1997. ,